Please wait while the formulary information is being retrieved.
LANSOPRAZOLE (LANSOPRAZOLE)
- Duodenal ulcer
- Gastroesophageal reflux disease
- Prevention of NSAId-induced gastric ulcer
- Duodenal ulcer due to h. pylori
- Erosive esophagitis
- Gastric hypersecretion with systemic mastocytosis
- Gastric ulcer
- Heartburn
- Helicobacter pylori gastritis
- Maintenance of healing duodenal ulcer
- Maintenance of healing erosive esophagitis
- NSAId-induced gastric ulcer
- Pathological gastric acid hypersecretory condition
- Zollinger-ellison syndrome
- Prevacid Solutab Delayed Release,disintegrating Tablet
- Prevacid Capsule,delayed Release
- Prevacid 24Hr Capsule,delayed Release
- Lansoprazole Delayed Release,disintegrating Tablet
- Lansoprazole Capsule,delayed Release
- Lansoprazole Cap, Delayed Release
- Heartburn Treatment 24 Hour Capsule,delayed Release
- By Indication
SoluTab 15 mg delayed release,disintegrating tablet
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
SoluTab 30 mg delayed release,disintegrating tablet
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
15 mg capsule,delayed release
- 1 capsule (15 mg) by oral route once daily before a meal
30 mg capsule,delayed release
- 1 capsule (30 mg) by oral route once daily before a meal
15 mg capsule,delayed release
- 1 capsule (15 mg) by oral route once daily before a meal
15 mg delayed release,disintegrating tablet
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
30 mg delayed release,disintegrating tablet
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
15 mg capsule,delayed release
- 1 capsule (15 mg) by oral route once daily before a meal
30 mg capsule,delayed release
- 1 capsule (30 mg) by oral route once daily before a meal
15 mg capsule,delayed release
- 1 capsule (15 mg) by oral route once daily before a meal
30 mg capsule,delayed release
- 1 capsule (30 mg) by oral route once daily before a meal
15 mg capsule,delayed release
- 1 capsule (15 mg) by oral route once daily before a meal
Duodenal ulcer
- 1 capsule (15 mg) before a meal by oral route once daily for 4 weeks
- 1 capsule (15 mg) by oral route once daily before a meal
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily for 4 weeks
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily for 4 weeks
- 1 capsule (30 mg) by oral route once daily before a meal
- 1 capsule (30 mg) by oral route once daily before a meal for 4 weeks
Duodenal ulcer due to h. pylori
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 12 hours
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 12 hours for 10 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day for 10 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day for 10 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 12 hours for 14 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day for 14 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 8 hours
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 3 times per day
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 3 times per day
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 3 times per day for 14 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 8 hours for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 3 times per day for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 12 hours
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 12 hours for 10 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day for 10 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day for 10 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 12 hours for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 8 hours
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 3 times per day
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 3 times per day
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 8 hours for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 3 times per day for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 3 times per day for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 12 hours
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 12 hours for 10 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 12 hours for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 8 hours
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 8 hours for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 12 hours
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 12 hours for 10 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 12 hours for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 8 hours
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 8 hours for 14 days
- 1 capsule (30 mg) by oral route 2 times per day before meals for14 days in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route 2 times per day before meals in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route every 12 hours before meals for 14 days in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route 3 times per day before meals for14 days in combination with amoxicillin
- 1 capsule (30 mg) by oral route 3 times per day before meals in combination with amoxicillin
- 1 capsule (30 mg) by oral route every 8 hours before meals for 14 days in combination with amoxicillin
- 1 capsule (30 mg) by oral route every 8 hours before meals in combination with amoxicillin
- 1 capsule (30 mg) by oral route 2 times per day before meals for10 days in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route every 12 hours before meals for 10 days in combination with amoxicillin
- 1 capsule (30 mg) by oral route every 12 hours before meals in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route 2 times per day before meals for 14 days in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route 2 times per day before meals incombination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route every 12 hours before meals for14 days in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route every 12 hours before meals in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route 3 times per day before meals for 14 days in combination with amoxicillin
- 2 capsules (30 mg) by oral route 3 times per day before meals incombination with amoxicillin
- 2 capsules (30 mg) by oral route every 8 hours before meals for 14 days in combination with amoxicillin
- 2 capsules (30 mg) by oral route every 8 hours before meals in combination with amoxicillin
- 2 capsules (30 mg) by oral route 2 times per day before meals for 10 days in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route every 12 hours before meals for10 days in combination with amoxicillin and clarithromycin
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day
Erosive esophagitis
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily for 8 weeks
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily for 8 weeks
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily for 8 weeks
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily for 8 weeks
- 1 capsule (30 mg) by oral route once daily before a meal for 8 weeks
- 1 capsule (30 mg) by oral route once daily before a meal
- 2 capsules (30 mg) by oral route once daily before a meal for 8 weeks
- 2 capsules (30 mg) by oral route once daily before a meal
Gastric hypersecretion with systemic mastocytosis
- 2 capsules (60 mg) by oral route once daily before a meal
- 2 tablets (60 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- Place 2 tablets (60 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
Gastric ulcer
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily for 8 weeks
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily for 8 weeks
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily for 8 weeks
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily for 8 weeks
- 1 capsule (30 mg) by oral route once daily before a meal for 8 weeks
- 1 capsule (30 mg) by oral route once daily before a meal
- 2 capsules (30 mg) by oral route once daily before a meal for 8 weeks
- 2 capsules (30 mg) by oral route once daily before a meal
Gastroesophageal reflux disease
- 1 capsule (30 mg) by oral route once daily before a meal for 8 weeks
- 1 capsule (30 mg) by oral route once daily before a meal
- 2 capsules (30 mg) by oral route once daily before a meal for 8 weeks
- 2 capsules (30 mg) by oral route once daily before a meal
Heartburn
- 1 capsule (15 mg) by oral route once daily before a meal
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily for 8 weeks
- 1 capsule (15 mg) by oral route once daily before a meal for 8 weeks
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily for 8 weeks
Helicobacter pylori gastritis
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 12 hours
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 12 hours for 10 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day for 10 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day for 10 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 12 hours for 14 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 2 times per day for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day for 14 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 8 hours
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 3 times per day
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 3 times per day
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route 3 times per day for 14 days
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route every 8 hours for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 3 times per day for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 12 hours
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 12 hours for 10 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day for 10 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day for 10 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 12 hours for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 2 times per day for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 2 times per day for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 8 hours
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 3 times per day
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 3 times per day
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route every 8 hours for 14 days
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route 3 times per day for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route 3 times per day for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 12 hours
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 12 hours for 10 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 12 hours for 14 days
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 8 hours
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route every 8 hours for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 12 hours
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 12 hours for 10 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 12 hours for 14 days
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 8 hours
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route every 8 hours for 14 days
- 1 capsule (30 mg) by oral route 2 times per day before meals for14 days in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route 2 times per day before meals in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route every 12 hours before meals for 14 days in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route 3 times per day before meals for14 days in combination with amoxicillin
- 1 capsule (30 mg) by oral route 3 times per day before meals in combination with amoxicillin
- 1 capsule (30 mg) by oral route every 8 hours before meals for 14 days in combination with amoxicillin
- 1 capsule (30 mg) by oral route every 8 hours before meals in combination with amoxicillin
- 1 capsule (30 mg) by oral route 2 times per day before meals for10 days in combination with amoxicillin and clarithromycin
- 1 capsule (30 mg) by oral route every 12 hours before meals for 10 days in combination with amoxicillin
- 1 capsule (30 mg) by oral route every 12 hours before meals in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route 2 times per day before meals for 14 days in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route 2 times per day before meals incombination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route every 12 hours before meals for14 days in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route every 12 hours before meals in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route 3 times per day before meals for 14 days in combination with amoxicillin
- 2 capsules (30 mg) by oral route 3 times per day before meals incombination with amoxicillin
- 2 capsules (30 mg) by oral route every 8 hours before meals for 14 days in combination with amoxicillin
- 2 capsules (30 mg) by oral route every 8 hours before meals in combination with amoxicillin
- 2 capsules (30 mg) by oral route 2 times per day before meals for 10 days in combination with amoxicillin and clarithromycin
- 2 capsules (30 mg) by oral route every 12 hours before meals for10 days in combination with amoxicillin and clarithromycin
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route 2 times per day
Maintenance of healing duodenal ulcer
- 1 capsule (15 mg) by oral route once daily before a meal
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily for 4 weeks
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily for 4 weeks
Maintenance of healing erosive esophagitis
- 1 capsule (15 mg) by oral route once daily before a meal
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
NSAId-induced gastric ulcer
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- Place 2 tablets (30 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily for 8 weeks
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (30 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily for 8 weeks
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- 2 tablets (30 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily for 8 weeks
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (30 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily for 8 weeks
- 1 capsule (30 mg) by oral route once daily before a meal for 8 weeks
- 1 capsule (30 mg) by oral route once daily before a meal
- 2 capsules (30 mg) by oral route once daily before a meal for 8 weeks
- 2 capsules (30 mg) by oral route once daily before a meal
Pathological gastric acid hypersecretory condition
- 2 capsules (60 mg) by oral route once daily before a meal
- 2 tablets (60 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- Place 2 tablets (60 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
Prevention of NSAId-induced gastric ulcer
- 1 capsule (15 mg) by oral route once daily before a meal
- 1 capsule (15 mg) by oral route once daily before a meal for 12 weeks
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily
- 1 tablet (15 mg) and place on top of the tongue where it will dissolve, then swallow by oral route once daily for 8 weeks
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily
- Place 1 tablet (15 mg) on top of the tongue where it will dissolve, then swallow by translingual route once daily for 8 weeks
Zollinger-ellison syndrome
- 2 capsules (60 mg) by oral route once daily before a meal
- 2 tablets (60 mg) and place on top of the tongue where they willdissolve, then swallow by oral route once daily
- Place 2 tablets (60 mg) on top of the tongue where they will dissolve, then swallow by translingual route once daily
- atazanavir
- Complera
- Edurant
- emtricitab-rilpivirine-tenofov
- nelfinavir
- Reyataz
- rilpivirine
- Viracept
Contraindicated
- Bosulif
- bosutinib
- Cellcept
- Cellcept Intravenous
- dasatinib
- erlotinib
- itraconazole
- ketoconazole
- methotrexate sodium
- methotrexate sodium (PF)
- mycophenolate mofetil
- mycophenolate mofetil HCl
- nilotinib
- Noxafil
- Onmel
- posaconazole
- Sporanox
- Sporanox Pulsepak
- Sprycel
- Tarceva
- Tasigna
Severe
Moderate
- Adderall
- Adderall Xr
- Amphetamine Salt Combo
- Astagraf Xl
- Ceftin
- cefuroxime axetil
- Dexedrine Spansule
- dextroamphetamine
- dextroamphetamine-amphetamine
- Hecoria
- Isentress
- Methotrexate (anti-rheumatic)
- Procentra
- Prograf
- raltegravir
- Rheumatrex
- tacrolimus
- Trexall
- Zenzedi
- None
Contraindicated
- Clostridium difficile infection
- Interstitial nephritis
- Severe hepatic disease
Severe
Moderate
- CYp2c19 poor metabolizer
- Fracture
- Hypomagnesemia
- Osteoporosis
- Vitamin b12 deficiency
LANSOPRAZOLE (LANSOPRAZOLE)
- Duodenal ulcer
- Gastroesophageal reflux disease
- Prevention of NSAId-induced gastric ulcer
- Duodenal ulcer due to h. pylori
- Erosive esophagitis
- Gastric hypersecretion with systemic mastocytosis
- Gastric ulcer
- Heartburn
- Helicobacter pylori gastritis
- Maintenance of healing duodenal ulcer
- Maintenance of healing erosive esophagitis
- NSAId-induced gastric ulcer
- Pathological gastric acid hypersecretory condition
- Zollinger-ellison syndrome
- Upper respiratory infection
- Diarrhea
- Dizziness
- Pruritus of skin
- Skin rash
More Frequent
Severe
Less Severe
- None
- Acute abdominal pain
- Appetite changes
- Arthralgias
- Constipation
- Cramps
- Headache disorder
- Musculoskeletal pain
- Nausea
- Pain in oropharynx
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acquired hemolytic anemia
- Acute pancreatitis
- Acute renal failure
- Agranulocytosis
- Anaphylaxis
- Angina
- Aplastic anemia
- Biliary calculus
- Cardiac arrhythmia
- Cataracts
- Cholecystitis
- Clostridium difficile infection
- Erythema multiforme
- Exfoliative dermatitis
- Fracture
- Glaucoma
- Hearing loss
- Hypersensitivity angiitis
- Hyponatremia
- Hypothyroidism
- Idiopathic thrombocytopenic purpura
- Interstitial nephritis
- Kidney stone
- Leukopenia
- Mucocutaneous candidiasis
- Myalgias
- Neutropenic disorder
- Pancytopenia
- Pharyngeal edema
- Pulmonary fibrosis
- Stevens-johnson syndrome
- Subacute cutaneous lupus erythematosus
- Systemic lupus erythematosus
- Throat constriction
- Thrombocytopenic disorder
- Thrombotic thrombocytopenic purpura
- Toxic epidermal necrolysis
- Urinary retention
Less Severe
- Abdominal distension
- Anemia
- Benign fundic gland polyposis of stomach
- Bursitis
- Candidiasis
- Chills
- Colitis
- Cough
- Depression
- Drowsy
- Dysarthria
- Dysgeusia
- Dyspareunia
- Edema
- Edema of the oral soft tissue
- Epistaxis
- Facial edema
- Fever
- Flatulence
- Flu-like symptoms
- Furred tongue
- General weakness
- Glossitis
- Gynecomastia
- Hypomagnesemia
- Lymphadenopathy
- Myositis
- Pain
- Paresthesia
- Parosmia
- Restless legs syndrome
- Stomatitis
- Symptoms of anxiety
- Tenesmus
- Tinnitus
- Tonsillitis
- Urticaria
- Vertigo
- Visual field defect
- Vitamin b12 deficiency
- Voice change
- Vomiting
- Xerostomia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Lansoprazole
Efficacy not established in pediatric trials for symptomatic GERD age <1 year.
Adhere to recommended dose and duration of therapy. Unknown safety and efficacy for long term treatment.
- 1 Day – 364 Days
- Efficacy not established in pediatric trials for symptomatic GERD age <1 year.
- Adhere to recommended dose and duration of therapy. Unknown safety and efficacy for long term treatment.
- 1 Years – 12 Years
- Efficacy not established in pediatric trials for symptomatic GERD age <1 year.
- Adhere to recommended dose and duration of therapy. Unknown safety and efficacy for long term treatment.
Lansoprazole
- Severity Level:
2
- Additional Notes: Available human data do not sug dev tox
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Lansoprazole
Insufficient human data avail; low mw, excretion possible
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data avail; low mw, excretion possible |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Lansoprazole
General-Prolonged use may dec absorption of Vitamin B-12. Avoid for >8 weeks duration unless for high risk patients (eg. oral corticosteroids or chronic NSAID use), erosive esophagitis, Barrett's esophagitis, pathologic hypersecretory condition, or demonstrated need for maint treatment. Musculoskeletal-Inc risk of fracture with high dose or use >1 year. Gastrointestinal-Long term use may be assoc w/ C. difficile or GI malignancy. Pulmonary-Long term use may be assoc w/pneumonia.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | N | N | Y | N |
BEERS: Y HEDIS: N STOPP: Y
No Known Risk
None
- None
| Duodenal ulcer | |
| K26 | Duodenal ulcer |
| K26.0 | Acute duodenal ulcer with hemorrhage |
| K26.1 | Acute duodenal ulcer with perforation |
| K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
| K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
| K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
| K26.5 | Chronic or unspecified duodenal ulcer with perforation |
| K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
| K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
| K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| Duodenal ulcer due to h. pylori | |
| B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
| Erosive esophagitis | |
| K22.1 | Ulcer of esophagus |
| K22.10 | Ulcer of esophagus without bleeding |
| K22.11 | Ulcer of esophagus with bleeding |
| Gastric hypersecretion with systemic mastocytosis | |
| C96.21 | Aggressive systemic mastocytosis |
| D47.02 | Systemic mastocytosis |
| K31.89 | Other diseases of stomach and duodenum |
| Gastric ulcer | |
| K25 | Gastric ulcer |
| K25.0 | Acute gastric ulcer with hemorrhage |
| K25.1 | Acute gastric ulcer with perforation |
| K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
| K25.3 | Acute gastric ulcer without hemorrhage or perforation |
| K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
| K25.5 | Chronic or unspecified gastric ulcer with perforation |
| K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
| K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
| K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| Gastroesophageal reflux disease | |
| K21 | Gastro-esophageal reflux disease |
| K21.0 | Gastro-esophageal reflux disease with esophagitis |
| K21.9 | Gastro-esophageal reflux disease without esophagitis |
| Heartburn | |
| R12 | Heartburn |
| Helicobacter pylori gastritis | |
| B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
| Maintenance of healing duodenal ulcer | |
| K26 | Duodenal ulcer |
| K26.0 | Acute duodenal ulcer with hemorrhage |
| K26.1 | Acute duodenal ulcer with perforation |
| K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
| K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
| K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
| K26.5 | Chronic or unspecified duodenal ulcer with perforation |
| K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
| K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
| K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| Maintenance of healing erosive esophagitis | |
| K22.1 | Ulcer of esophagus |
| K22.10 | Ulcer of esophagus without bleeding |
| K22.11 | Ulcer of esophagus with bleeding |
| NSAId-induced gastric ulcer | |
| K25 | Gastric ulcer |
| K25.0 | Acute gastric ulcer with hemorrhage |
| K25.1 | Acute gastric ulcer with perforation |
| K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
| K25.3 | Acute gastric ulcer without hemorrhage or perforation |
| K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
| K25.5 | Chronic or unspecified gastric ulcer with perforation |
| K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
| K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
| K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| K27 | Peptic ulcer, site unspecified |
| K27.0 | Acute peptic ulcer, site unspecified, with hemorrhage |
| K27.1 | Acute peptic ulcer, site unspecified, with perforation |
| K27.2 | Acute peptic ulcer, site unspecified, with both hemorrhage and perforation |
| K27.3 | Acute peptic ulcer, site unspecified, without hemorrhage or perforation |
| K27.4 | Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage |
| K27.5 | Chronic or unspecified peptic ulcer, site unspecified, with perforation |
| K27.6 | Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation |
| K27.7 | Chronic peptic ulcer, site unspecified, without hemorrhage or perforation |
| K27.9 | Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation |
| K28 | Gastrojejunal ulcer |
| K28.0 | Acute gastrojejunal ulcer with hemorrhage |
| K28.1 | Acute gastrojejunal ulcer with perforation |
| K28.2 | Acute gastrojejunal ulcer with both hemorrhage and perforation |
| K28.3 | Acute gastrojejunal ulcer without hemorrhage or perforation |
| K28.4 | Chronic or unspecified gastrojejunal ulcer with hemorrhage |
| K28.5 | Chronic or unspecified gastrojejunal ulcer with perforation |
| K28.6 | Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation |
| K28.7 | Chronic gastrojejunal ulcer without hemorrhage or perforation |
| K28.9 | Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| Pathological gastric acid hypersecretory condition | |
| K31.89 | Other diseases of stomach and duodenum |
| Prevention of NSAId-induced gastric ulcer | |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAId) |
| Zollinger-ellison syndrome | |
| E16.4 | Increased secretion of gastrin |
| 0-9 | A-Z |
|---|---|
| B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
| B96.81 | Helicobacter pylori [h. pylori] as the cause of diseases classified elsewhere |
| C96.21 | Aggressive systemic mastocytosis |
| D47.02 | Systemic mastocytosis |
| E16.4 | Increased secretion of gastrin |
| K21 | Gastro-esophageal reflux disease |
| K21.0 | Gastro-esophageal reflux disease with esophagitis |
| K21.9 | Gastro-esophageal reflux disease without esophagitis |
| K22.1 | Ulcer of esophagus |
| K22.1 | Ulcer of esophagus |
| K22.10 | Ulcer of esophagus without bleeding |
| K22.10 | Ulcer of esophagus without bleeding |
| K22.11 | Ulcer of esophagus with bleeding |
| K22.11 | Ulcer of esophagus with bleeding |
| K25 | Gastric ulcer |
| K25 | Gastric ulcer |
| K25.0 | Acute gastric ulcer with hemorrhage |
| K25.0 | Acute gastric ulcer with hemorrhage |
| K25.1 | Acute gastric ulcer with perforation |
| K25.1 | Acute gastric ulcer with perforation |
| K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
| K25.2 | Acute gastric ulcer with both hemorrhage and perforation |
| K25.3 | Acute gastric ulcer without hemorrhage or perforation |
| K25.3 | Acute gastric ulcer without hemorrhage or perforation |
| K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
| K25.4 | Chronic or unspecified gastric ulcer with hemorrhage |
| K25.5 | Chronic or unspecified gastric ulcer with perforation |
| K25.5 | Chronic or unspecified gastric ulcer with perforation |
| K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
| K25.6 | Chronic or unspecified gastric ulcer with both hemorrhage and perforation |
| K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
| K25.7 | Chronic gastric ulcer without hemorrhage or perforation |
| K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| K25.9 | Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| K26 | Duodenal ulcer |
| K26 | Duodenal ulcer |
| K26.0 | Acute duodenal ulcer with hemorrhage |
| K26.0 | Acute duodenal ulcer with hemorrhage |
| K26.1 | Acute duodenal ulcer with perforation |
| K26.1 | Acute duodenal ulcer with perforation |
| K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
| K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
| K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
| K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
| K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
| K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
| K26.5 | Chronic or unspecified duodenal ulcer with perforation |
| K26.5 | Chronic or unspecified duodenal ulcer with perforation |
| K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
| K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
| K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
| K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
| K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| K27 | Peptic ulcer, site unspecified |
| K27.0 | Acute peptic ulcer, site unspecified, with hemorrhage |
| K27.1 | Acute peptic ulcer, site unspecified, with perforation |
| K27.2 | Acute peptic ulcer, site unspecified, with both hemorrhage and perforation |
| K27.3 | Acute peptic ulcer, site unspecified, without hemorrhage or perforation |
| K27.4 | Chronic or unspecified peptic ulcer, site unspecified, with hemorrhage |
| K27.5 | Chronic or unspecified peptic ulcer, site unspecified, with perforation |
| K27.6 | Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation |
| K27.7 | Chronic peptic ulcer, site unspecified, without hemorrhage or perforation |
| K27.9 | Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation |
| K28 | Gastrojejunal ulcer |
| K28.0 | Acute gastrojejunal ulcer with hemorrhage |
| K28.1 | Acute gastrojejunal ulcer with perforation |
| K28.2 | Acute gastrojejunal ulcer with both hemorrhage and perforation |
| K28.3 | Acute gastrojejunal ulcer without hemorrhage or perforation |
| K28.4 | Chronic or unspecified gastrojejunal ulcer with hemorrhage |
| K28.5 | Chronic or unspecified gastrojejunal ulcer with perforation |
| K28.6 | Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation |
| K28.7 | Chronic gastrojejunal ulcer without hemorrhage or perforation |
| K28.9 | Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| K31.89 | Other diseases of stomach and duodenum |
| K31.89 | Other diseases of stomach and duodenum |
| R12 | Heartburn |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAId) |
Formulary Reference Tool